BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20510802)

  • 21. [Efficacy analysis on laparoscopic simultaneous resection of primary colorectal cancer and liver metastases].
    Zhu DX; He GD; Mao YH; Wei Y; Ren L; Lin Q; Wang XY; Xu JM
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jun; 23(6):584-588. PubMed ID: 32521979
    [No Abstract]   [Full Text] [Related]  

  • 22. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
    Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
    Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases.
    Nishioka Y; Moriyama J; Matoba S; Kuroyanagi H; Hashimoto M; Shindoh J
    Dig Surg; 2018; 35(3):187-195. PubMed ID: 28848205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.
    Flood MP; Das AA; Soucisse ML; Kong J; Ramsay RG; Michael M; Loveday BPT; Warrier SK; Heriot AG
    Dis Colon Rectum; 2021 Jun; 64(6):754-764. PubMed ID: 33742615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.
    Heslin MJ; Medina-Franco H; Parker M; Vickers SM; Aldrete J; Urist MM
    Arch Surg; 2001 Mar; 136(3):318-23. PubMed ID: 11231853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases.
    Cauchy F; Aussilhou B; Dokmak S; Fuks D; Gaujoux S; Farges O; Faivre S; Lepillé D; Belghiti J
    Ann Surg; 2012 Nov; 256(5):746-52; discussion 752-4. PubMed ID: 23095618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse oncological outcome of surgical site infection after liver resection for colorectal liver metastases.
    Fukami Y; Maeda A; Takayama Y; Takahashi T; Uji M; Kaneoka Y
    Surg Today; 2019 Feb; 49(2):170-175. PubMed ID: 30225661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative Triplet Chemotherapy and Cetuximab in Patients With RAS Wild Type High Recurrence Risk or Borderline Resectable Colorectal Cancer Liver Metastases.
    Pietrantonio F; Di Bartolomeo M; Cotsoglou C; Mennitto A; Berenato R; Morano F; Coppa J; Perrone F; Iacovelli R; Milione M; Alessi A; Vaiani M; Bossi I; Ricchini F; Scotti M; Caporale M; Bajetta E; de Braud F; Mazzaferro V
    Clin Colorectal Cancer; 2017 Sep; 16(3):e191-e198. PubMed ID: 27979717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases.
    Karoui M; Vigano L; Goyer P; Ferrero A; Luciani A; Aglietta M; Delbaldo C; Cirillo S; Capussotti L; Cherqui D
    Br J Surg; 2010 Sep; 97(9):1354-62. PubMed ID: 20603857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reverse strategy for synchronous colorectal liver metastases Therapeutic protocol completion, 3-year survival and progression pattern in 32 patients].
    Straka M; Migrová M; Soumarová R; Burda L; Selingerová I
    Rozhl Chir; 2016; 95(7):280-6. PubMed ID: 27523176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous versus staged resection for synchronous colorectal cancer liver metastases.
    Martin RC; Augenstein V; Reuter NP; Scoggins CR; McMasters KM
    J Am Coll Surg; 2009 May; 208(5):842-50; discussion 850-2. PubMed ID: 19476847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?
    Adam R; Bhangui P; Poston G; Mirza D; Nuzzo G; Barroso E; Ijzermans J; Hubert C; Ruers T; Capussotti L; Ouellet JF; Laurent C; Cugat E; Colombo PE; Milicevic M
    Ann Surg; 2010 Nov; 252(5):774-87. PubMed ID: 21037433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative complications following aggressive repeat hepatectomy for colorectal liver metastasis have adverse oncological outcomes.
    Fukami Y; Kaneoka Y; Maeda A; Takayama Y; Onoe S
    Surg Today; 2017 Jan; 47(1):99-107. PubMed ID: 27117689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of local recurrence.
    Mima K; Beppu T; Chikamoto A; Miyamoto Y; Nakagawa S; Kuroki H; Okabe H; Hayashi H; Sakamoto Y; Watanabe M; Kikuchi K; Baba H
    Int J Clin Oncol; 2013 Oct; 18(5):847-55. PubMed ID: 22940848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A decision analysis model predicts the optimal treatment pathway for patients with colorectal cancer and resectable synchronous liver metastases.
    Aloia TA; Fahy BN
    Clin Colorectal Cancer; 2008 May; 7(3):197-201. PubMed ID: 18621638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases.
    Devaud N; Kanji ZS; Dhani N; Grant RC; Shoushtari H; Serrano PE; Nanji S; Greig PD; McGilvray I; Moulton CA; Wei A; Gallinger S; Cleary SP
    HPB (Oxford); 2014 May; 16(5):475-80. PubMed ID: 23927606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
    Bova R; Kamphues C; Neuhaus P; Puhl G
    Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the Optimal Timing for Liver Surgery of Resectable Synchronous Liver Metastases from Colorectal Cancer?
    Inoue Y; Imai Y; Osumi W; Shimizu T; Asakuma M; Hirokawa F; Hayashi M; Uchiyama K
    Am Surg; 2017 Jan; 83(1):45-53. PubMed ID: 28234125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.